Asafo & Co. is advising Akdital in its IPO on the Casablanca Stock Exchange. The offering will take place through a capital increase and a share sale. Valued at 1.2 billion dirhams (US$ 110 million), the transaction will help fund Akdital’s development plan. With just five clinics in 2019, by the end of this year […]
Healthcare, Pharma & Life Sciences
IPOs
United Arab Emirates
Burjeel Holdings opens subscription period for IPO in UAE
Burjeel Holdings has announced the offer price range and the opening of the subscription period for its Initial Public Offering (IPO) on the Abu Dhabi Securities Exchange (ADX). The opening of the subscription period for the Offering commences 30th September 2022 and will continue until Tuesday 4th October 2022 for the First Tranche (offering to individual […]
Healthcare, Pharma & Life Sciences
News
Other
Trowers & Hamlins: RCSI Bahrain launches new solar farm project
The Royal College of Surgeons in Ireland – Medical University of Bahrain (“RCSI Bahrain”) has successfully completed the development and launch of its campus solar farm project. Covering 12,000 sqm, the solar farm is expected to be completed in January 2023. RCSI Bahrain is a constituent university of RCSI, which was established in Dublin, Ireland […]
Deal & transactions
Egypt
Healthcare, Pharma & Life Sciences
GSK Group completes demerger of Haleon Group. The advisors
Global healthcare company GlaxoSmithKline Services Unlimited (“GSK Group”) has completed the demerger of its consumer healthcare business to form global consumer healthcare company Haleon Group. The transaction was valued at GBP 55 million (approximately USD 63.8 million). The separation of the Consumer Healthcare project was completed on 18 July 2022. Helmy Hamza & Partners, Baker McKenzie‘s Cairo […]
Deal & transactions
Healthcare, Pharma & Life Sciences
Other
Pharmaceutical Institute (PHI) completes acquisition by Kelix Bio
KELIX bio, a pan-African biopharmaceutical platform, has entered into a binding agreement to acquire Moroccan Pharmaceutical Institute (“PHI”). This investment marks KELIX bio’s first entry into Morocco – an important market in the company’s strategy – at a time when the Kingdom is accelerating the successful rollout of AMO (Assurance Maladie Obligatoire), a far-reaching plan […]
Deal & transactions
Healthcare, Pharma & Life Sciences
Other
Bayan Dental acquires majority stake in Sky Dental. The advisors
Meysan Partners advised Al Bayan Medical Company (“Bayan Dental”) in connection with its acquisition of a majority stake in Sky for the Management of Specialized Medical Centers (“Sky Dental”), a Kuwaiti dental clinic owned and managed by high profile Kuwaiti dentists. Founded in 2002, Bayan Dental is one of the first private dental clinics in Kuwait, […]
Deal & transactions
Healthcare, Pharma & Life Sciences
United Arab Emirates
GluCare.Health partners with Novo Nordisk on its weight management pilot
GluCare.Health, a hybrid digital therapeutics company focused on diabetes, have signed a partnership agreement to launch a value-based weight management pilot with Danish multinational pharmaceutical company, Novo Nordisk. Set to begin in September 2022, the trial will launch with a150-patient weight management pilot programme in the United Arab Emirates (UAE). The aim of the trial is […]
Deal & transactions
Healthcare, Pharma & Life Sciences
United Arab Emirates
ADQ to acquire Turkish pharmaceuticals company Birgi Mefar Group
Turkish pharmaceuticals company Birgi Mefar Group (BMG) has entered into a definitive acquisition agreement with ADQ, an Abu Dhabi- based investment and holding company. BMG is one of Turkey’s leading producers of sterile injectable products, such as vials and pre-filled syringes for vaccines, and has operations in over 30 countries. This acquisition comes as part […]
Capital Markets
Healthcare, Pharma & Life Sciences
United Arab Emirates
Baker McKenzie advises on the sale of New You Medical
New You Medical Center, a day surgery medical and beauty center in Saudi Arabia focused on bariatric procedures, has completed the sale of a majority equity stake of 51% to Nomu-listed Arabian International Healthcare Holding Co. (“Tibbiyah”), the healthcare arm of Al Faisaliah Group. The consideration is structured through a combination of cash and earn-out […]
